VERU Price / Book | VERU INC.

VERU INC. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

VERU INC. price/book ratio for the quarter ending 2026-06-30 was 1.89, a 239.54% increase year-over-year.
VERU INC. price/book ratio for the quarter ending 2026-03-31 was 1.02, a 97.00% decline year-over-year.
VERU INC. price/book ratio for the quarter ending 2025-12-31 was 0.92, a 97.42% decline year-over-year.
VERU INC. price/book ratio for the quarter ending 2025-09-30 was 3, a 13.85% decline year-over-year.
VERU INC. price/book ratio for fiscal 2026 was 1.89.
VERU INC. price/book ratio for fiscal 2025 was 0.92, a 97.42% decline from fiscal 2024.
VERU INC. price/book ratio for fiscal 2024 was 35.73, a 74.96% increase from fiscal 2023.
VERU INC. price/book ratio for fiscal 2023 was 20.42, a 76.40% decline from fiscal 2022.

Available history: 2010-09-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.89	$53.54M	$28.38M
2026-03-31	1.02	$35.63M	$34.79M
2025-12-31	0.92	$34.19M	$37.12M
2025-09-30	3	$55.09M	$18.33M
2025-06-30	0.56	$8.53M	$15.34M
2025-03-31	34.13	$718.26M	$21.05M
2024-12-31	35.73	$951.5M	$26.63M
2024-09-30	3.49	$112.72M	$32.32M
2024-06-30	32.69	$1.23B	$37.62M
2024-03-31	22.66	$1.02B	$45.21M
2023-12-31	20.42	$1.05B	$51.6M
2023-09-30	33.58	$660.84M	$19.68M
2023-06-30	51.43	$1.06B	$20.65M
2023-03-31	43.92	$957.89M	$21.81M
2022-12-31	86.54	$4.26B	$49.19M
2022-09-30	112.02	$9.27B	$82.8M
2022-06-30	77.48	$9.05B	$116.87M
2022-03-31	28.44	$3.87B	$136M
2021-12-31	31.86	$4.71B	$148M
2021-09-30	44.15	$6.82B	$154.52M
2021-06-30	41.58	$6.44B	$154.97M
2021-03-31	55.24	$8.59B	$155.5M
2020-12-31	127.59	$6.22B	$48.75M
2020-09-30	60.79	$1.83B	$30.11M
2020-06-30	56.53	$2.33B	$41.28M
2020-03-31	69.04	$2.15B	$31.11M
2019-12-31	73.5	$2.18B	$29.64M
2019-09-30	43.45	$1.4B	$32.33M
2019-06-30	39.75	$1.38B	$34.74M
2019-03-31	27.33	$916.65M	$33.54M
2018-12-31	23.77	$876.65M	$36.88M
2018-09-30	26.63	$785.05M	$29.48M
2018-06-30	30.14	$1.08B	$35.87M
2018-03-31	23.43	$968.58M	$41.33M
2017-12-31	13.55	$606.58M	$44.75M
2017-09-30	29.1	$1.41B	$48.45M
2017-06-30	10.03	$329.05M	$32.81M
2017-03-31	9.44	$316.52M	$33.53M
2016-12-31	8.09	$285.18M	$35.24M
2016-09-30	10.46	$354.9M	$33.93M
2016-06-30	10.31	$366.06M	$35.51M
2016-03-31	15.58	$542.87M	$34.85M
2015-12-31	12.12	$420.85M	$34.72M
2015-09-30	13.83	$458.34M	$33.13M
2015-06-30	16.02	$518.69M	$32.38M
2015-03-31	26.26	$815.44M	$31.06M
2014-12-31	38.61	$1.13B	$29.26M
2014-09-30	35.78	$1B	$28.07M
2014-06-30	54.93	$1.59B	$28.97M
2014-03-31	80.76	$2.24B	$27.75M
2013-12-31	83.41	$2.44B	$29.27M
2013-09-30	90.05	$2.83B	$31.4M
2013-06-30	105.64	$2.82B	$26.73M
2013-03-31	80.19	$2.08B	$25.89M
2012-12-31	84.09	$2.06B	$24.48M
2012-09-30	84.41	$2.04B	$24.22M
2012-06-30	82.01	$1.64B	$19.99M
2012-03-31	87.26	$1.51B	$17.34M
2011-12-31	74.15	$1.26B	$16.96M
2011-09-30	67.55	$1.13B	$16.75M
2010-09-30	87.66	$1.41B	$16.13M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.89	$53.54M	$28.38M
2025-12-31	0.92	$34.19M	$37.12M
2024-12-31	35.73	$951.5M	$26.63M
2023-12-31	20.42	$1.05B	$51.6M
2022-12-31	86.54	$4.26B	$49.19M
2021-12-31	31.86	$4.71B	$148M
2020-12-31	127.59	$6.22B	$48.75M
2019-12-31	73.5	$2.18B	$29.64M
2018-12-31	23.77	$876.65M	$36.88M
2017-12-31	13.55	$606.58M	$44.75M
2016-12-31	8.09	$285.18M	$35.24M
2015-12-31	12.12	$420.85M	$34.72M
2014-12-31	38.61	$1.13B	$29.26M
2013-12-31	83.41	$2.44B	$29.27M
2012-12-31	84.09	$2.06B	$24.48M
2011-12-31	74.15	$1.26B	$16.96M
2010-09-30	87.66	$1.41B	$16.13M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Kairos Pharma, LTD. (KAPA)	United States	$0.041B
SCYNEXIS INC (SCYX)	United States	$0.045B
PDS Biotechnology Corp (PDSB)	United States	$0.045B
Incannex Healthcare Inc. (IXHL)		$0.040B	-22.32
Grace Therapeutics, Inc. (GRCE)		$0.046B	-1.83
Karyopharm Therapeutics Inc. (KPTI)	United States	$0.039B	-0.98
Edesa Biotech, Inc. (EDSA)	Canada	$0.039B
Werewolf Therapeutics, Inc. (HOWL)	United States	$0.047B
CervoMed Inc. (CRVO)	United States	$0.038B	-1.39
Celularity Inc (CELU)	United States	$0.038B	-0.34